Recruiting Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38) NCT06535568 Conditions Acute Coronary Syndrome, Antineoplastic Agents, Arterial Occlusive Diseases, +23 more Locations IRCCS Auxologico Milano — Milan, MI, Italy View Trial Details
Recruiting Phase I Study of JYP0322 in ROS1 Fusion-Positive Solid Tumors NCT06128148 Conditions Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +12 more Locations Sun Yat-Sen University Cancer Center — Guangzhou, Guangdong, China View Trial Details
Completed TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC NCT04518852 Conditions Adenocarcinoma, Antineoplastic Agents, Carcinoma, +13 more Locations Sichuan Cancer Hospital and Research Institute — Chengdu, Sichuan, China View Trial Details
Completed A Safety and Dose-finding Study of JNJ-26483327, a Drug in Development for Cancer, for Patients With Advanced and/or Refractory Solid Malignancies. NCT00676299 Conditions Advanced Malignancies, Antineoplastic Protocols, Clinical Trial, Phase 1, +4 more Locations Not specified View Trial Details
Active, Not Recruiting Savolitinib vs. Sunitinib in MET-driven PRCC. NCT03091192 Conditions Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more Locations Research Site — La Jolla, California, United States Research Site — Atlanta, Georgia, United States Research Site — Chicago, Illinois, United States Research Site — Iowa City, Iowa, United States View all 59 locations View more locations Show fewer locations Loading locations... View Trial Details
